Peerbridge Health Raises $7M, Submits Next-Generation Cardiac Device for FDA Review

Peerbridge Health has closed a $7 million funding round and submitted its next-generation wearable cardiac monitoring device, the Cor MDx™, for FDA 510(k) clearance. The company also announced the appointment of medical technology executive Dan Reuvers to its Board of Directors and the expansion of its sales team.

Advancing Access to Cardiac Diagnostics

Heart disease remains the leading cause of death in the United States, yet access to timely, affordable cardiac diagnostics is limited for many patients. Peerbridge Health says its mission is to address this gap through more accessible, high-fidelity cardiac monitoring.

“We believe that life-saving cardiac diagnostics should not be a luxury, yet access to affordable diagnostics is still out of reach for so many people,” said Chris Darland, CEO of Peerbridge Health. “Too many families delay or avoid cardiac testing because it’s either too expensive or not offered in their community.”

The Cor MDx™ is designed to provide real-time, hospital-grade cardiac monitoring. Pending FDA clearance, the device is expected to launch later this year, supported by the latest funding round.

Leadership Expansion

As part of its growth strategy, Peerbridge appointed Dan Reuvers to its Board of Directors. Reuvers brings more than 30 years of leadership experience in the medical technology sector, including roles as CEO of Tactile Medical and president of the neuro division at Integra LifeSciences. He also serves on the board of directors of Etac.

“Dan brings exactly the kind of experience we need right now as we move into this next phase,” said Darland. “His experience enriches our leadership team, and we’re thrilled to officially welcome him to our board.”

Sales Growth and Market Focus

Peerbridge has also expanded its sales force across three regions. The team will focus on extending access to cardiac diagnostics into primary care and cardiology clinics, with the goal of detecting disease earlier and reducing hospitalizations.